Biologics in Paediatric Crohn's Disease
Crohn's disease affects increasing numbers of children worldwide. Generally, childhood-onset disease runs a more severe course than in adults and has a greater impact on quality of life. Therapy in children must take account of a different set of risks for toxicity compared to adults, but also...
Saved in:
Main Authors: | Oliver Gouldthorpe, Anthony G. Catto-Smith, George Alex |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2011/287574 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enteral Nutrition in Crohn’s Disease: An Underused Therapy
by: S. Kansal, et al.
Published: (2013-01-01) -
Disseminated Tuberculosis Mimicking as Crohn’s Disease in a Paediatric Patient
by: Elizabeth Feenstra, et al.
Published: (2023-01-01) -
Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
by: Edyta Szymanska, et al.
Published: (2016-12-01) -
Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease
by: Vojtech Dotlacil, et al.
Published: (2025-01-01) -
Clinical usefulness of the Mucosal Inflammation Noninvasive Index in newly diagnosed paediatric Crohn’s disease patients
by: Roma B. Herman, et al.
Published: (2021-10-01)